Terms: = Cervical cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Treatment
13 results:
1. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
[TBL] [Abstract] [Full Text] [Related]
2. PHLDA1 is a P53 target gene involved in P53-mediated cell apoptosis.
Song X; Zhou L; Yang W; Li X; Ma J; Qi K; Liang R; Li M; Xie L; Su T; Huang D; Liang B
Mol Cell Biochem; 2024 Mar; 479(3):653-664. PubMed ID: 37155089
[TBL] [Abstract] [Full Text] [Related]
3. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas.
Gupta AK; Kumar M
Cancer Biomark; 2023; 36(1):31-52. PubMed ID: 36245368
[TBL] [Abstract] [Full Text] [Related]
4. FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt/β-catenin signaling to drive cervical cancer proliferation, invasion, and EMT.
Wang T; Li W; Ye B; Zhang S; Lei X; Zhang D
J BUON; 2021; 26(4):1279-1291. PubMed ID: 34564982
[TBL] [Abstract] [Full Text] [Related]
5. Combination treatment of cervical cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
Wang J
Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
[TBL] [Abstract] [Full Text] [Related]
6. Intention-to-Treat Analysis of Radical Trachelectomy for Early-Stage cervical cancer With Special Reference to Oncologic Failures: Single-Institutional Experience in Hungary.
Póka R; Molnár S; Daragó P; Lukács J; Lampé R; Krasznai Z; Hernádi Z
Int J Gynecol Cancer; 2017 Sep; 27(7):1438-1445. PubMed ID: 28604460
[TBL] [Abstract] [Full Text] [Related]
7. Reproducibility and interoperator reliability of obtaining images and measurements of the cervix and uterus with brachytherapy treatment applicators in situ using transabdominal ultrasound.
van Dyk S; Garth M; Oates A; Kondalsamy-Chennakesavan S; Schneider M; Bernshaw D; Narayan K
Brachytherapy; 2016; 15(1):71-8. PubMed ID: 26614235
[TBL] [Abstract] [Full Text] [Related]
8. HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients.
Hinten F; Meeuwis KA; van Rossum MM; de Hullu JA
Crit Rev Oncol Hematol; 2012 Nov; 84(2):161-80. PubMed ID: 22425015
[TBL] [Abstract] [Full Text] [Related]
9. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis.
Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965
[TBL] [Abstract] [Full Text] [Related]
10. A novel fusion protein diphtheria toxin-stem cell factor (DT-SCF)-purification and characterization.
Potala S; Verma RS
Appl Biochem Biotechnol; 2010 Nov; 162(5):1258-69. PubMed ID: 20084469
[TBL] [Abstract] [Full Text] [Related]
11. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of human papillomavirus-16 long control region activity by interferon-gamma overcome by p300 overexpression.
Fontaine V; van der Meijden E; ter Schegget J
Mol Carcinog; 2001 May; 31(1):27-36. PubMed ID: 11398195
[TBL] [Abstract] [Full Text] [Related]
13. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
[TBL] [Abstract] [Full Text] [Related]
